RYLVX
Price
$116.87
Change
+$1.32 (+1.14%)
Updated
Sep 26 closing price
Net Assets
142.8M
VIVAX
Price
$72.78
Change
+$0.60 (+0.83%)
Updated
Sep 26 closing price
Net Assets
202.84B
Interact to see
Advertisement

RYLVX vs VIVAX

Header iconRYLVX vs VIVAX Comparison
Open Charts RYLVX vs VIVAXBanner chart's image
Rydex S&P 500 Pure Value A
Price$116.87
Change+$1.32 (+1.14%)
VolumeN/A
Net Assets142.8M
Vanguard Value Index I
Price$72.78
Change+$0.60 (+0.83%)
VolumeN/A
Net Assets202.84B
RYLVX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYLVX vs. VIVAX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLVX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. RYLVX (143M). VIVAX pays higher dividends than RYLVX: VIVAX (1.99) vs RYLVX (0.84). RYLVX was incepted earlier than VIVAX: RYLVX (21 years) vs VIVAX (33 years). RYLVX (1.59) is less costly to investors than VIVAX (0.17). RYLVX is a more actively managed with annual turnover of: 2642.00 vs. VIVAX (9.00). RYLVX has a lower initial minimum investment than VIVAX: RYLVX (2500) vs VIVAX (3000). RYLVX annual gain was more profitable for investors over the last year : 13.16 vs. VIVAX (7.64). RYLVX return over 5 years is better than : 114.40 vs. VIVAX (81.78).
RYLVXVIVAXRYLVX / VIVAX
Total Expense Ratio1.540.17906%
Annual Report Gross Expense Ratio1.590.17935%
Fund Existence21 years33 years-
Gain YTD10.71210.222105%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets143M203B0%
Annual Yield % from dividends0.841.9942%
Returns for 1 year13.167.64172%
Returns for 3 years45.8550.2291%
Returns for 5 years114.4081.78140%
Returns for 10 years105.56147.6871%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDHL1.840.19
+11.52%
Redhill Biopharma Ltd
IRON65.553.05
+4.88%
Disc Medicine
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
ASTS49.09-0.30
-0.61%
AST SpaceMobile
AMTD1.17-0.03
-2.89%
AMTD IDEA Group